The Bypass Angioplasty Revascularization Investigation 2 Diabetes ( BARI 2D ) trial randomized patients with ischemic heart disease and anatomy suitable to revascularization to ( 1 ) initial OMT with revascularization if needed or ( 2 ) initial revascularization plus OMT and found no difference in major cardiovascular events .